Most patients with cancer-associated deep venous thrombosis (DVT) or pulmonary embolism (PE) in the U.S.
DVT-PE in cancer: Oral anticoagulant edoxaban non-inferior to enoxaparin
DVT-PE in cancer: Oral anticoagulant edoxaban…
DVT-PE in cancer: Oral anticoagulant edoxaban non-inferior to enoxaparin
Most patients with cancer-associated deep venous thrombosis (DVT) or pulmonary embolism (PE) in the U.S.